Today, February 15, Qlife opened the Egoo Health webshop for the Egoo system with CRP Capsule. The Egoo CRP Capsule is the first product in Qlife’s Egoo portfolio to be introduced to the home market. Both system and capsules can be ordered on
Today, February 15, Qlife opened the Egoo Health webshop for the Egoo system with CRP Capsule. The Egoo CRP Capsule is the first product in Qlife’s Egoo portfolio to be introduced to the home market. Both system and capsules can be ordered on https://www.egoo.health/egoo-shop
“With this launch, Qlife really can start delivering on our vision of bringing lifestyle biomarker testing with quantitative precise data to a wider health-conscious audience and for home use”, says Thomas Warthoe, CEO of Qlife. “Based on Qlife’s own information, this is the world’s first self-test platform for immuno-diagnostics biomarkers.”
CRP capsules are available as single orders or as subscriptions and initially launched without medical claims. Qlife will file for CE-mark, which allows for broader clinical applicability of the platform.
Qlife was founded based on the idea that Egoo Health could help people lead a better life by using the diagnostics self-testing platform Egoo Health, Empowering a Better Being.
For more information please contact:
Thomas Warthoe, CEO
tw@egoo.health
+45 21 63 35 34
Qlife is a medical device company born to challenge the status quo in healthcare. We work to shift the perspective and turn today’s view on healthcare into tomorrow’s focus on health- empowerment. We are on a quest to empower people with more accessible ways to understand their health – so that they can move beyond reactive care towards proactive wellbeing. It’s how we contribute to improving quality of life for every individual and for the greater society.
Shares for Qlife are being traded on Nasdaq First North Growth Market in Stockholm with G&W Fondkommission as certified advisor (phone: +46 (0) 8-503 000 50, e-mail: ca@gwkapital.se).
Read more on Egoo.health, Qlifeholding.com or follow us on LinkedIn.